Skip to main content

D. E. Shaw & Co., Inc.

Position in BEAM — Beam Therapeutics Inc.

CIK 1009207 New York, NY

Position in BEAM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,481,402
+$3,707,044 QoQ
Shares Held
130,577
+367.4% QoQ
Ownership
0.126%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 274 holders
Holding Since
Mar 2021
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BEAM Over Time

Shares Held

Position Value (USD)

Derivatives in BEAM

reported options exposure · as of Sep 30, 2025
CallValue
$1,356,693
CallShares
55,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. BEAM ranks #97 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BEAM

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,481,402 130,577
2025-12-31 $774,358 27,935
2025-09-30 $1,356,693 55,900
2024-06-30 $204,333 8,721
2022-09-30 $2,095,921 43,995
2022-09-30 $1,429,200 30,000
2021-12-31 $1,376,166 17,269
2021-09-30 $870,100 10,000
2021-09-30 $5,154,733 59,243
2021-06-30 $1,287,100 10,000
2021-03-31 $495,927 6,196
2021-03-31 $1,600,800 20,000